Vaxcyte, Inc. Common Stock(PCVX)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$55.10
52-Week Range
$29.08 – $65.00
YTD
+18.61%
IV Rank (30D)
32.74
Straddle Price
$5.90
P/C Vol Ratio
2.48
Market Cap
$7.8B
Fair Value
+5.8% vs price
Confidence: 30% Alpha Score: 0.10

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.50%
Beta vs SPY1.00
Cost of Equity (CAPM)10.00% (VRP-adj)
WACC10.03%
Volatility Risk Premium+49.3pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.8B
Return on Equity (TTM)-31.6%
Book / Price40.8% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$53.01 (Market Anchor value)
SMA 20 / Bollinger Mid$49.39
Bollinger Width / SMA2040.1% (drives anchor stability)
Net Debt$-0.3B
Market Cap$7B
Peers used for multiples: BIIB, MRNA, NBIX, TECH (SIC-code peers; ETF co-membership was sector-incoherent)
Blended Fair Value
$59.79
Current Price
$56.52
Deviation
+5.8%
Forward-Return Rank SHORT gated
?
Horizon Expected α z Pred Blended z Rank % Active?
21d -3.8% -0.18 -0.54 69.9%
42d -6.2% -0.32 -0.54 69.9%
63d -8.9% -0.78 -0.54 69.9%
Expected α = forward-return point estimate vs SPY (e.g., +7.5% means the predictor expects this stock to outperform SPY by 7.5% over that horizon). For SHORT direction the model uses a different ranking metric (conviction-weighted deviation, not the LGBM prediction); Expected α is shown for reference. flags rows where Expected α disagrees with the FV direction — two independent signals are in conflict; conviction is low even if rank looks extreme.
Forward-Return Rank. A proprietary ensemble of a machine-learning forward-return model and a conviction-weighted fundamental score, ranked cross-sectionally each day across the S&P 500 (and broader universes on the screener). Each stock is scored at three horizons (21/42/63 trading days). "Active" = top/bottom 5% AND all risk filters pass. Backtested mean alpha vs SPY on active picks: 21d LONG +13.4%, 63d +34.9% (S&P 500, walk-forward). Past performance is not indicative of future results.
Value vs momentum conflict ⚠. The "FV direction" (long/short) comes from the fundamentals-based engine — price vs intrinsic value. The "Expected α" comes from a separate machine-learning predictor trained on ~12 features (sector, options-implied move, beta, institutional flow, etc.). Sometimes the two disagree: a stock is overvalued by fundamentals but the predictor expects it to keep outperforming (sector or momentum tailwinds). When all 3 horizons disagree, treat the direction signal as low-conviction — neither model is strongly recommending a position.
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 25.0× · 3 peers
Peer EV/EBITDA n/a 0% median 19.8× · 3 peers
Peer P/B $83.78 22% median 3.8× · 4 peers
Peer P/S n/a 0% median 6.5× · 4 peers
Market Anchor (SMA50) $53.01 78% stability 69% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-26 · updated 2026-06-26 20:59:30.580000
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$7.8B

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -1.02% 6
Feb +3.46% 6
Mar -11.48% 6
Apr +0.17% 6
May +4.52% 6
Jun +2.74% 6
Jul +3.03% 5
Aug +9.90% 5
Sep +0.92% 5
Oct +19.94% 5
Nov -0.56% 5
Dec +9.29% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $49.66
SMA 50: $52.93
SMA 200: $49.58
Current: $56.52
EMA 12: $51.85
EMA 26: $51.19
MACD: 0.6660 | Signal: 1.1137
BEARISH
ADX (14): 27.70
TREND
+DI: 26.29
−DI: 12.80
Momentum Oscillators
RSI (14): 67.46
NEUTRAL
Stoch %K: 89.33
Stoch %D: 85.90
Williams %R: -1.15
Volume & Volatility
BB Upper: $55.43
BB Lower: $43.90
OVERBOUGHT
OBV: -10,534,897
Vol SMA 20: 1,855,604
Vol ROC: 324.42%
ATR: $2.35
True Range: $3.01
HV 20: 45.6%
HV 30: 49.1%
HV 60: 46.3%

Data Summary
Data Points: 500
Last Updated: 2026-06-26T21:15:11.280000
Date Range: 2024-06-28T00:00:00 – 2026-06-26T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
7 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-06 After-Close 9.91% 4.61% 0.47x Within
2024-11-05 After-Close 6.25% 3.24% 0.52x Within
2025-02-25 After-Close 19.09% 0.18% 0.01x Within
2025-05-07 After-Close 14.02% 8.72% 0.62x Within
2025-08-06 After-Close 11.74% 9.06% 0.77x Within
2025-11-04 After-Close 19.83% 2.49% 0.13x Within
2026-02-24 After-Close 12.37% 1.70% 0.14x Within
2026-05-06 After-Close 8.36% 9.84% 1.18x Exceeded
Options Activity
IV Rank (30D)
32.74
IV Rank (7D)
32.74
Avg IV
97.6%
Straddle (30D)
$5.90
Straddle (7D)
$5.90
P/C Volume
2.48
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.98
Correlation (SPY)
26.1%
0.07
Ann. Volatility
46.5%
SPY Volatility
12.5%

Moderate volatility - stock generally follows market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 136,956,611 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

335 filers159,740,931 shares$8.26B value116.64% of float
# Filer Shares Value % of Total % of Float Period
1 JANUS HENDERSON GROUP PLC 16,575,875 $960.23M 11.63% 12.10% 2026-03-31
2 FMR LLC Custodian 16,492,861 $958.40M 11.60% 12.04% 2026-03-31
3 RA CAPITAL MANAGEMENT, L.P. 11,474,599 $666.79M 8.07% 8.38% 2026-03-31
4 BlackRock, Inc. Custodian 10,971,816 $637.57M 7.72% 8.01% 2026-03-31
5 VANGUARD GROUP INC Custodian 12,193,986 $562.63M 6.81% 8.90% 2025-12-31
6 WELLINGTON MANAGEMENT GROUP LLP Custodian 5,614,597 $326.26M 3.95% 4.10% 2026-03-31
7 Paradigm Biocapital Advisors LP 4,793,020 $278.52M 3.37% 3.50% 2026-03-31
8 STATE STREET CORP 4,440,519 $258.04M 3.12% 3.24% 2026-03-31
9 Deep Track Capital, LP 4,300,000 $249.87M 3.03% 3.14% 2026-03-31
10 WESTFIELD CAPITAL MANAGEMENT CO LP 3,646,138 $211.88M 2.57% 2.66% 2026-03-31
11 GEODE CAPITAL MANAGEMENT, LLC Custodian 3,201,283 $186.06M 2.25% 2.34% 2026-03-31
12 Kynam Capital Management, LP 2,922,335 $169.82M 2.06% 2.13% 2026-03-31
13 D. E. Shaw & Co., Inc. Custodian 2,865,318 $166.50M 2.02% 2.09% 2026-03-31
14 Caligan Partners LP 2,060,719 $119.75M 1.45% 1.50% 2026-03-31
15 JENNISON ASSOCIATES LLC 1,698,011 $98.67M 1.19% 1.24% 2026-03-31
16 Polar Capital Holdings Plc 1,425,788 $82.85M 1.00% 1.04% 2026-03-31
17 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,403,948 $81.58M 0.99% 1.03% 2026-03-31
18 MAVERICK CAPITAL LTD 1,377,738 $80.06M 0.97% 1.01% 2026-03-31
19 EVENTIDE ASSET MANAGEMENT, LLC 1,374,292 $79.84M 0.97% 1.00% 2026-03-31
20 Pivotal bioVenture Partners Investment Advisor LLC 1,372,425 $79.75M 0.97% 1.00% 2026-03-31
21 UBS Group AG Custodian 1,337,390 $77.72M 0.94% 0.98% 2026-03-31
22 GOLDMAN SACHS GROUP INC Custodian 1,275,036 $74.09M 0.90% 0.93% 2026-03-31
23 BANK OF AMERICA CORP /DE/ Custodian 1,216,843 $70.71M 0.86% 0.89% 2026-03-31
24 Bellevue Group AG 1,190,697 $69.19M 0.84% 0.87% 2026-03-31
25 Assenagon Asset Management S.A. 1,164,813 $67.69M 0.82% 0.85% 2026-03-31
11 filers$61.75M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $17.61M 28.52% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $16.00M 25.91% 2026-03-31
3 JANE STREET GROUP, LLC Custodian $13.65M 22.11% 2026-03-31
4 CITADEL ADVISORS LLC Custodian $5.51M 8.92% 2026-03-31
5 DIADEMA PARTNERS LP $3.09M 5.00% 2026-03-31
6 Nantahala Capital Management, LLC $2.05M 3.31% 2026-03-31
7 GOLDMAN SACHS GROUP INC Custodian $1.46M 2.36% 2026-03-31
8 TUDOR INVESTMENT CORP ET AL $1.16M 1.88% 2026-03-31
9 GROUP ONE TRADING LLC Custodian $755.43K 1.22% 2026-03-31
10 Persistent Asset Partners Ltd $323.31K 0.52% 2026-03-31
11 SIMPLEX TRADING, LLC Custodian $151.09K 0.24% 2026-03-31
8 filers$102.74M notional
# Filer Notional Value % of Total Period
1 JANE STREET GROUP, LLC Custodian $33.31M 32.42% 2026-03-31
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $25.30M 24.63% 2026-03-31
3 Caption Management, LLC $23.26M 22.63% 2026-03-31
4 BOOTHBAY FUND MANAGEMENT, LLC $11.70M 11.39% 2026-03-31
5 CITADEL ADVISORS LLC Custodian $5.97M 5.81% 2026-03-31
6 SIMPLEX TRADING, LLC Custodian $2.60M 2.53% 2026-03-31
7 GROUP ONE TRADING LLC Custodian $482.31K 0.47% 2026-03-31
8 Walleye Capital LLC $127.84K 0.12% 2026-03-31
Insider Activity
Latest: 2026-06-23
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-23 Moncef Slaoui Director Grant (A) +26,061 opt EDGAR
2026-06-18 GRANT PICKERING CHIEF EXECUTIVE OFFICER Mixed −24,236 $52.04 -$1.28M EDGAR
2026-06-18 ANDREW GUGGENHIME PRESIDENT AND CFO Mixed $29.18 -$476.5K EDGAR
2026-06-16 Heath Lukatch Director Award (A) +2,265 EDGAR
2026-06-16 Halley E Gilbert Director Award (A) +2,265 EDGAR
2026-06-16 Jacks Lee Director Award (A) +2,265 EDGAR
2026-06-16 OLIVIER BRANDICOURT Director Award (A) +2,194 EDGAR
2026-06-16 Anne S Drapeau Director Award (A) +2,265 EDGAR
2026-06-16 Teri Loxam Director Award (A) +2,265 EDGAR
2026-06-16 John Furey Director Award (A) +2,265 EDGAR
2026-06-16 Carlos V Paya Director Award (A) +2,265 EDGAR
2026-06-03 Jim Wassil CHIEF OPERATING OFFICER Sell (S) −2,250 $49.52 -$111.4K EDGAR
2026-05-01 Jim Wassil CHIEF OPERATING OFFICER Sell (S) −2,250 $56.83 -$127.9K EDGAR
2026-04-08 Elvia Cowan SVP, Finance & CAO Mixed $42.96 -$102.2K EDGAR
2026-04-03 Jim Wassil CHIEF OPERATING OFFICER Sell (S) −2,250 $58.43 -$131.5K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
26 insiders · @ $56.52
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Peter Kolchinsky 10%+ Owner 5,283,818 $298.64M -$44.98M 1 2020-10-01
2 RA Capital Healthcare Fund LP 10%+ Owner 5,169,254 $292.17M -$54.09M 1 2020-10-09
3 DAVID BONDERMAN 10%+ Owner 5,074,574 $286.81M $37.01M 2 2020-12-17
4 KURT VON EMSTER Director 4,168,718 $235.62M $200.0K 4 2021-06-03
5 Patrick J Heron Director 2,309,554 $130.54M $4.00M 3 2021-06-03
6 Robert Lorne Hopfner Director 1,577,316 $89.15M -$20.55M 11 2021-06-03
7 GRANT PICKERING CHIEF EXECUTIVE OFFICER 632,379 $35.74M -$37.46M 75 2026-06-18
8 ANDREW GUGGENHIME PRESIDENT AND CFO 166,245 $9.40M -$17.59M 47 2026-06-18
9 Jim Wassil CHIEF OPERATING OFFICER 158,795 $8.98M -$10.57M 49 2026-06-03
10 Harpreet S. Dhaliwal Chief Technical Ops Officer 75,976 $4.29M -$454.9K 10 2026-03-11
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-06-18
Last 30d: 3 filings · $1.9M notice value  ·  Last 90d: 6 filings · $2.4M notice value · 4 unique filers · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Parsed directly from EDGAR primary-doc XML. Daily refresh; new filings typically appear here the morning after they hit EDGAR.

Top 90-day filers: PICKERING GRANT (1, $1.3M) · GUGGENHIME ANDREW (1, $530K) · Wassil Jim (3, $374K) · Cowan Elvia (1, $180K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-18 GUGGENHIME ANDREW Officer 10,000 $530.0K 2026-06-18 UBS Financial Services, Inc 10b5-1 EDGAR
2026-06-18 PICKERING GRANT Officer 24,461 $1.28M 2026-06-18 UBS Financial Services, Inc. 10b5-1 EDGAR
2026-06-01 Wassil Jim Officer 2,250 $114.8K 2026-06-01 UBS Financial Services, Inc. 10b5-1 EDGAR
2026-05-01 Wassil Jim Officer 2,250 $128.8K 2026-05-01 UBS Financial Services, Inc. 10b5-1 EDGAR
2026-04-07 Cowan Elvia Officer 3,000 $180.0K 2026-04-07 UBS Financial Services, Inc 10b5-1 EDGAR
2026-04-01 Wassil Jim Officer 2,250 $130.7K 2026-04-01 UBS Financial Services, Inc. 10b5-1 EDGAR
2026-03-17 Cowan Elvia Officer 1,892 $105.7K 2026-03-17 UBS Financial Services, Inc 10b5-1 EDGAR
2026-03-11 Cowan Elvia Officer 2,500 $146.6K 2026-03-11 UBS Financial Services, Inc 10b5-1 EDGAR
2026-03-10 Wassil Jim Officer 7,395 $432.4K 2026-03-10 UBS Financial Services, Inc. 10b5-1 EDGAR
2025-12-31 HARPREET DHALIWAL Officer 9,743 $454.9K 2025-12-31 Morgan Stanley Smith Barney LLC … EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio2.6
EV/EBITDA-7.0
TTM Net Income$-0.9B
TTM EPS$-6.88
ROE-31.6%